Want to join the conversation?
$BCR's sales from Vascular for 4Q15 declined by 2% to $239.3MM from last year, while Urology sales remained virtually unchanged at $217.9MM. Sales from Surgical Specialties increased by 5% to $152.8MM and Oncology sales rose slightly to $237.8MM from $237.5MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?